ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2358

Chest Pain and Angina Pectoris in Rheumatoid Arthritis: Frequency and Prediction of Cardiovascular Mortality

Jose Felix Restrepo1, Inmaculada del Rincon1, Carlos Lorenzo1, Daniel Battafarano2 and Agustin Escalante1, 1Internal Medicine-Rheumatology, University of Texas Health Science Center at San Antonio, San Antonio, TX, 2Rheumatology, San Antonio Military Medical Center (SAMMC), San Antonio, TX

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Cardiovascular disease and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Rheumatoid Arthritis – Clinical Aspects Poster III: Comorbidities

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

 Despite increased cardiovascular (CV) risk in rheumatoid arthritis (RA), chest pain and angina have received little attention among RA patients.  We examined the frequency of chest pain and angina, and their ability to predict CV mortality in an RA cohort, compared to controls from the general population.

Methods:

We recruited consecutive RA patients from public and private rheumatology practices. All patients underwent a comprehensive clinical and psychosocial assessment, and were followed prospectively over time until they died, or were lost to follow-up. Population-based controls were sampled from census tracks and recruited in their homes and followed prospectively as well. Patients and controls were interviewed by certified personnel for the presence of chest pain and angina pectoris using the Rose angina questionnaire, a standardized instrument designed for assessing the presence of angina pectoris in epidemiological studies.  We ascertained deaths from family members, physician or hospital records, obituaries or public databases. We obtained certificates for all deaths. Deaths were attributed to CV causes using established criteria.

We used logistic regression to compare the baseline frequency of chest pain and angina between RA and controls, adjusting for age and sex. We used Cox proportional hazard models to examine the age- and sex-adjusted association of chest pain and angina with CV mortality in cases and controls.

Results:

We studied 1211 RA patients, of whom 906 were women (75%) and 5158 controls, of whom 2937 were women (56%). The mean follow-up time was 8745 person-years for RA cohort and 73,403 person-years for the control group. During this time there were 278 deaths in RA cohort, for a mortality rate 1.3 per 100 person-years, and 547 in the controls, for a mortality rate of 0.3 per 100 person-years.

Chest pain was more frequent in RA than in controls, with an age-sex adjusted frequency of 47% vs 31%, p < 0.0001, as was angina, age- and sex-adjusted frequencies of 11.7% vs 4.2%, p < 0.001, (Figure). Chest pain was a significant predictor of CV mortality in the RA patients (age-sex adjusted) HR 1.65, (95% CI 1.13-2.39), but not in the controls, adjusted HR 1.09 (95% CI 0.85, 1.41). Angina predicted CV mortality in both cohorts, adjusted HR 1.84(95% CI 1.0, 3.36) for RA and adjusted HR 1.77 (95% CI 1.15-2.72) for controls.

Conclusion:

These findings suggest that chest pain and angina are more frequent in RA than in controls, and that these symptoms are significant predictors of CV mortality.   Clinicians should be aware that RA patients experiencing chest pain may be at high risk of death from CV causes.

 


Disclosure: J. F. Restrepo, None; I. del Rincon, None; C. Lorenzo, None; D. Battafarano, None; A. Escalante, None.

To cite this abstract in AMA style:

Restrepo JF, del Rincon I, Lorenzo C, Battafarano D, Escalante A. Chest Pain and Angina Pectoris in Rheumatoid Arthritis: Frequency and Prediction of Cardiovascular Mortality [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/chest-pain-and-angina-pectoris-in-rheumatoid-arthritis-frequency-and-prediction-of-cardiovascular-mortality/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/chest-pain-and-angina-pectoris-in-rheumatoid-arthritis-frequency-and-prediction-of-cardiovascular-mortality/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology